External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study

Objective To externally validate Yonsei nomogram. Methods From 2000 through 2018, 3526 consecutive patients underwent on‐clamp PN for cT1 renal masses at 23 centers were included. All patients had two kidneys, preoperative eGFR ≥60 ml/min/1.73 m2, and a minimum follow‐up of 12 months. New‐onset CKD...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of urology Vol. 30; no. 3; pp. 308 - 317
Main Authors Abdel Raheem, Ali, Landi, Isotta, Alowidah, Ibrahim, Capitanio, Umberto, Montorsi, Francesco, Larcher, Alessandro, Derweesh, Ithaar, Ghali, Fady, Mottrie, Alexander, Mazzone, Elio, De Naeyer, Geert, Campi, Riccardo, Sessa, Francesco, Carini, Marco, Minervini, Andrea, Raman, Jay D., Rjepaj, Chris J., Kriegmair, Maximilian C., Autorino, Riccardo, Veccia, Alessandro, Mir, Maria Carmen, Claps, Francesco, Choi, Young Deuk, Ham, Won Sik, Santok, Glen Denmer, Tadifa, John Paul, Syling, Justin, Furlan, Maria, Simeone, Claudio, Bada, Maida, Celia, Antonio, Carrión, Diego M., Aguilera Bazan, Alfredo, Ruiz, Cristina Ballesteros, Malki, Manar, Barber, Neil, Hussain, Muddassar, Micali, Salvatore, Puliatti, Stefano, Ghaith, Ahmed, Hagras, Ayman, Ghoneem, Ayman M., Eissa, Ahmed, Alqahtani, Abdulrahman, Rumaih, Abdullah, Alwahabi, Abdelaziz, Alenzi, Mohammed Jayed, Pavan, Nicola, Traunero, Fabio, Antonelli, Alessandro, Porcaro, Antonio Benito, Illiano, Ester, Costantini, Elisabetta, Rha, Koon Ho
Format Journal Article
LanguageEnglish
Published Australia Wiley Subscription Services, Inc 01.03.2023
Subjects
Calibration
chronic kidney disease
Epidermal growth factor receptors
external validation
functional outcomes
Glomerular Filtration Rate
Humans
Kidney diseases
Kidney Neoplasms - pathology
Middle Aged
Nephrectomy
Nephrectomy - methods
Nomograms
partial nephrectomy
Renal Insufficiency, Chronic - surgery
Retrospective Studies
Yonsei nomogram
external validation
chronic kidney disease
functional outcomes
Yonsei nomogram
partial nephrectomy
Online AccessGet full text

Cover

Abstract Objective To externally validate Yonsei nomogram. Methods From 2000 through 2018, 3526 consecutive patients underwent on‐clamp PN for cT1 renal masses at 23 centers were included. All patients had two kidneys, preoperative eGFR ≥60 ml/min/1.73 m2, and a minimum follow‐up of 12 months. New‐onset CKD was defined as upgrading from CKD stage I or II into CKD stage ≥III. We obtained the CKD‐free progression probabilities at 1, 3, 5, and 10 years for all patients by applying the nomogram found at https://eservices.ksmc.med.sa/ckd/. Thereafter, external validation of Yonsei nomogram for estimating new‐onset CKD stage ≥III was assessed by calibration and discrimination analysis. Results and limitation Median values of patients' age, tumor size, eGFR and follow‐up period were 47 years (IQR: 47–62), 3.3 cm (IQR: 2.5–4.2), 90.5 ml/min/1.73 m2 (IQR: 82.8–98), and 47 months (IQR: 27–65), respectively. A total of 683 patients (19.4%) developed new‐onset CKD. The 5‐year CKD‐free progression rate was 77.9%. Yonsei nomogram demonstrated an AUC of 0.69, 0.72, 0.77, and 0.78 for the prediction of CKD stage ≥III at 1, 3, 5, and 10 years, respectively. The calibration plots at 1, 3, 5, and 10 years showed that the model was well calibrated with calibration slope values of 0.77, 0.83, 0.76, and 0.75, respectively. Retrospective database collection is a limitation of our study. Conclusions The largest external validation of Yonsei nomogram showed good calibration properties. The nomogram can provide an accurate estimate of the individual risk of CKD‐free progression on long‐term follow‐up.
AbstractList To externally validate Yonsei nomogram.OBJECTIVETo externally validate Yonsei nomogram.From 2000 through 2018, 3526 consecutive patients underwent on-clamp PN for cT1 renal masses at 23 centers were included. All patients had two kidneys, preoperative eGFR ≥60 ml/min/1.73 m2, and a minimum follow-up of 12 months. New-onset CKD was defined as upgrading from CKD stage I or II into CKD stage ≥III. We obtained the CKD-free progression probabilities at 1, 3, 5, and 10 years for all patients by applying the nomogram found at https://eservices.ksmc.med.sa/ckd/. Thereafter, external validation of Yonsei nomogram for estimating new-onset CKD stage ≥III was assessed by calibration and discrimination analysis.METHODSFrom 2000 through 2018, 3526 consecutive patients underwent on-clamp PN for cT1 renal masses at 23 centers were included. All patients had two kidneys, preoperative eGFR ≥60 ml/min/1.73 m2, and a minimum follow-up of 12 months. New-onset CKD was defined as upgrading from CKD stage I or II into CKD stage ≥III. We obtained the CKD-free progression probabilities at 1, 3, 5, and 10 years for all patients by applying the nomogram found at https://eservices.ksmc.med.sa/ckd/. Thereafter, external validation of Yonsei nomogram for estimating new-onset CKD stage ≥III was assessed by calibration and discrimination analysis.Median values of patients' age, tumor size, eGFR and follow-up period were 47 years (IQR: 47-62), 3.3 cm (IQR: 2.5-4.2), 90.5 ml/min/1.73 m2 (IQR: 82.8-98), and 47 months (IQR: 27-65), respectively. A total of 683 patients (19.4%) developed new-onset CKD. The 5-year CKD-free progression rate was 77.9%. Yonsei nomogram demonstrated an AUC of 0.69, 0.72, 0.77, and 0.78 for the prediction of CKD stage ≥III at 1, 3, 5, and 10 years, respectively. The calibration plots at 1, 3, 5, and 10 years showed that the model was well calibrated with calibration slope values of 0.77, 0.83, 0.76, and 0.75, respectively. Retrospective database collection is a limitation of our study.RESULTS AND LIMITATIONMedian values of patients' age, tumor size, eGFR and follow-up period were 47 years (IQR: 47-62), 3.3 cm (IQR: 2.5-4.2), 90.5 ml/min/1.73 m2 (IQR: 82.8-98), and 47 months (IQR: 27-65), respectively. A total of 683 patients (19.4%) developed new-onset CKD. The 5-year CKD-free progression rate was 77.9%. Yonsei nomogram demonstrated an AUC of 0.69, 0.72, 0.77, and 0.78 for the prediction of CKD stage ≥III at 1, 3, 5, and 10 years, respectively. The calibration plots at 1, 3, 5, and 10 years showed that the model was well calibrated with calibration slope values of 0.77, 0.83, 0.76, and 0.75, respectively. Retrospective database collection is a limitation of our study.The largest external validation of Yonsei nomogram showed good calibration properties. The nomogram can provide an accurate estimate of the individual risk of CKD-free progression on long-term follow-up.CONCLUSIONSThe largest external validation of Yonsei nomogram showed good calibration properties. The nomogram can provide an accurate estimate of the individual risk of CKD-free progression on long-term follow-up.
Abstract Objective To externally validate Yonsei nomogram. Methods From 2000 through 2018, 3526 consecutive patients underwent on‐clamp PN for cT1 renal masses at 23 centers were included. All patients had two kidneys, preoperative eGFR ≥60 ml/min/1.73 m2, and a minimum follow‐up of 12 months. New‐onset CKD was defined as upgrading from CKD stage I or II into CKD stage ≥III. We obtained the CKD‐free progression probabilities at 1, 3, 5, and 10 years for all patients by applying the nomogram found at https://eservices.ksmc.med.sa/ckd/ . Thereafter, external validation of Yonsei nomogram for estimating new‐onset CKD stage ≥III was assessed by calibration and discrimination analysis. Results and limitation Median values of patients' age, tumor size, eGFR and follow‐up period were 47 years (IQR: 47–62), 3.3 cm (IQR: 2.5–4.2), 90.5 ml/min/1.73 m2 (IQR: 82.8–98), and 47 months (IQR: 27–65), respectively. A total of 683 patients (19.4%) developed new‐onset CKD. The 5‐year CKD‐free progression rate was 77.9%. Yonsei nomogram demonstrated an AUC of 0.69, 0.72, 0.77, and 0.78 for the prediction of CKD stage ≥III at 1, 3, 5, and 10 years, respectively. The calibration plots at 1, 3, 5, and 10 years showed that the model was well calibrated with calibration slope values of 0.77, 0.83, 0.76, and 0.75, respectively. Retrospective database collection is a limitation of our study. Conclusions The largest external validation of Yonsei nomogram showed good calibration properties. The nomogram can provide an accurate estimate of the individual risk of CKD‐free progression on long‐term follow‐up.
Objective To externally validate Yonsei nomogram. Methods From 2000 through 2018, 3526 consecutive patients underwent on‐clamp PN for cT1 renal masses at 23 centers were included. All patients had two kidneys, preoperative eGFR ≥60 ml/min/1.73 m2, and a minimum follow‐up of 12 months. New‐onset CKD was defined as upgrading from CKD stage I or II into CKD stage ≥III. We obtained the CKD‐free progression probabilities at 1, 3, 5, and 10 years for all patients by applying the nomogram found at https://eservices.ksmc.med.sa/ckd/. Thereafter, external validation of Yonsei nomogram for estimating new‐onset CKD stage ≥III was assessed by calibration and discrimination analysis. Results and limitation Median values of patients' age, tumor size, eGFR and follow‐up period were 47 years (IQR: 47–62), 3.3 cm (IQR: 2.5–4.2), 90.5 ml/min/1.73 m2 (IQR: 82.8–98), and 47 months (IQR: 27–65), respectively. A total of 683 patients (19.4%) developed new‐onset CKD. The 5‐year CKD‐free progression rate was 77.9%. Yonsei nomogram demonstrated an AUC of 0.69, 0.72, 0.77, and 0.78 for the prediction of CKD stage ≥III at 1, 3, 5, and 10 years, respectively. The calibration plots at 1, 3, 5, and 10 years showed that the model was well calibrated with calibration slope values of 0.77, 0.83, 0.76, and 0.75, respectively. Retrospective database collection is a limitation of our study. Conclusions The largest external validation of Yonsei nomogram showed good calibration properties. The nomogram can provide an accurate estimate of the individual risk of CKD‐free progression on long‐term follow‐up.
To externally validate Yonsei nomogram. From 2000 through 2018, 3526 consecutive patients underwent on-clamp PN for cT1 renal masses at 23 centers were included. All patients had two kidneys, preoperative eGFR ≥60 ml/min/1.73 m2, and a minimum follow-up of 12 months. New-onset CKD was defined as upgrading from CKD stage I or II into CKD stage ≥III. We obtained the CKD-free progression probabilities at 1, 3, 5, and 10 years for all patients by applying the nomogram found at https://eservices.ksmc.med.sa/ckd/. Thereafter, external validation of Yonsei nomogram for estimating new-onset CKD stage ≥III was assessed by calibration and discrimination analysis. Median values of patients' age, tumor size, eGFR and follow-up period were 47 years (IQR: 47-62), 3.3 cm (IQR: 2.5-4.2), 90.5 ml/min/1.73 m2 (IQR: 82.8-98), and 47 months (IQR: 27-65), respectively. A total of 683 patients (19.4%) developed new-onset CKD. The 5-year CKD-free progression rate was 77.9%. Yonsei nomogram demonstrated an AUC of 0.69, 0.72, 0.77, and 0.78 for the prediction of CKD stage ≥III at 1, 3, 5, and 10 years, respectively. The calibration plots at 1, 3, 5, and 10 years showed that the model was well calibrated with calibration slope values of 0.77, 0.83, 0.76, and 0.75, respectively. Retrospective database collection is a limitation of our study. The largest external validation of Yonsei nomogram showed good calibration properties. The nomogram can provide an accurate estimate of the individual risk of CKD-free progression on long-term follow-up.
ObjectiveTo externally validate Yonsei nomogram.MethodsFrom 2000 through 2018, 3526 consecutive patients underwent on‐clamp PN for cT1 renal masses at 23 centers were included. All patients had two kidneys, preoperative eGFR ≥60 ml/min/1.73 m2, and a minimum follow‐up of 12 months. New‐onset CKD was defined as upgrading from CKD stage I or II into CKD stage ≥III. We obtained the CKD‐free progression probabilities at 1, 3, 5, and 10 years for all patients by applying the nomogram found at https://eservices.ksmc.med.sa/ckd/. Thereafter, external validation of Yonsei nomogram for estimating new‐onset CKD stage ≥III was assessed by calibration and discrimination analysis.Results and limitationMedian values of patients' age, tumor size, eGFR and follow‐up period were 47 years (IQR: 47–62), 3.3 cm (IQR: 2.5–4.2), 90.5 ml/min/1.73 m2 (IQR: 82.8–98), and 47 months (IQR: 27–65), respectively. A total of 683 patients (19.4%) developed new‐onset CKD. The 5‐year CKD‐free progression rate was 77.9%. Yonsei nomogram demonstrated an AUC of 0.69, 0.72, 0.77, and 0.78 for the prediction of CKD stage ≥III at 1, 3, 5, and 10 years, respectively. The calibration plots at 1, 3, 5, and 10 years showed that the model was well calibrated with calibration slope values of 0.77, 0.83, 0.76, and 0.75, respectively. Retrospective database collection is a limitation of our study.ConclusionsThe largest external validation of Yonsei nomogram showed good calibration properties. The nomogram can provide an accurate estimate of the individual risk of CKD‐free progression on long‐term follow‐up.
Author Malki, Manar
De Naeyer, Geert
Minervini, Andrea
Bada, Maida
Antonelli, Alessandro
Micali, Salvatore
Autorino, Riccardo
Ruiz, Cristina Ballesteros
Rha, Koon Ho
Aguilera Bazan, Alfredo
Mir, Maria Carmen
Porcaro, Antonio Benito
Hagras, Ayman
Alqahtani, Abdulrahman
Carrión, Diego M.
Montorsi, Francesco
Illiano, Ester
Puliatti, Stefano
Ham, Won Sik
Syling, Justin
Choi, Young Deuk
Traunero, Fabio
Claps, Francesco
Ghaith, Ahmed
Capitanio, Umberto
Hussain, Muddassar
Alenzi, Mohammed Jayed
Pavan, Nicola
Abdel Raheem, Ali
Santok, Glen Denmer
Furlan, Maria
Simeone, Claudio
Raman, Jay D.
Sessa, Francesco
Rjepaj, Chris J.
Tadifa, John Paul
Campi, Riccardo
Rumaih, Abdullah
Alowidah, Ibrahim
Landi, Isotta
Barber, Neil
Alwahabi, Abdelaziz
Veccia, Alessandro
Mazzone, Elio
Mottrie, Alexander
Costantini, Elisabetta
Larcher, Alessandro
Carini, Marco
Ghoneem, Ayman M.
Celia, Antonio
Derweesh, Ithaar
Kriegmair, Maximilian C.
Ghali, Fady
Eissa, Ahmed
Author_xml – sequence: 1
  givenname: Ali
  orcidid: 0000-0002-9294-2665
  surname: Abdel Raheem
  fullname: Abdel Raheem, Ali
  email: aliraheem82@yahoo.com, a-hassan@ksmc.med.sa
  organization: Tanta University
– sequence: 2
  givenname: Isotta
  surname: Landi
  fullname: Landi, Isotta
  organization: Center for Neuroscience and Cognitive Systems at University of Trento, Italian Institute of Technology
– sequence: 3
  givenname: Ibrahim
  surname: Alowidah
  fullname: Alowidah, Ibrahim
  organization: King Saud Medical City
– sequence: 4
  givenname: Umberto
  surname: Capitanio
  fullname: Capitanio, Umberto
  organization: Urological Research Institute (URI), IRCCS Ospedale San Raffaele
– sequence: 5
  givenname: Francesco
  surname: Montorsi
  fullname: Montorsi, Francesco
  organization: Urological Research Institute (URI), IRCCS Ospedale San Raffaele
– sequence: 6
  givenname: Alessandro
  surname: Larcher
  fullname: Larcher, Alessandro
  organization: Department of Urology, UC San Diego School of Medicine
– sequence: 7
  givenname: Ithaar
  surname: Derweesh
  fullname: Derweesh, Ithaar
  organization: Department of Urology, UC San Diego School of Medicine
– sequence: 8
  givenname: Fady
  surname: Ghali
  fullname: Ghali, Fady
  organization: Department of Urology, UC San Diego School of Medicine
– sequence: 9
  givenname: Alexander
  surname: Mottrie
  fullname: Mottrie, Alexander
  organization: Orsi Academy
– sequence: 10
  givenname: Elio
  surname: Mazzone
  fullname: Mazzone, Elio
  organization: Orsi Academy
– sequence: 11
  givenname: Geert
  surname: De Naeyer
  fullname: De Naeyer, Geert
  organization: OLV Hospital
– sequence: 12
  givenname: Riccardo
  orcidid: 0000-0001-5237-0888
  surname: Campi
  fullname: Campi, Riccardo
  organization: University of Florence
– sequence: 13
  givenname: Francesco
  surname: Sessa
  fullname: Sessa, Francesco
  organization: University of Florence
– sequence: 14
  givenname: Marco
  surname: Carini
  fullname: Carini, Marco
  organization: University of Florence, Careggi Hospital
– sequence: 15
  givenname: Andrea
  orcidid: 0000-0002-1994-1324
  surname: Minervini
  fullname: Minervini, Andrea
  organization: University of Florence, Careggi Hospital
– sequence: 16
  givenname: Jay D.
  surname: Raman
  fullname: Raman, Jay D.
  organization: Penn State Health Milton S. Hershey Medical Center
– sequence: 17
  givenname: Chris J.
  surname: Rjepaj
  fullname: Rjepaj, Chris J.
  organization: Penn State Health Milton S. Hershey Medical Center
– sequence: 18
  givenname: Maximilian C.
  surname: Kriegmair
  fullname: Kriegmair, Maximilian C.
  organization: University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg
– sequence: 19
  givenname: Riccardo
  orcidid: 0000-0001-7045-7725
  surname: Autorino
  fullname: Autorino, Riccardo
  organization: VCU Health
– sequence: 20
  givenname: Alessandro
  orcidid: 0000-0001-5947-3206
  surname: Veccia
  fullname: Veccia, Alessandro
  organization: VCU Health
– sequence: 21
  givenname: Maria Carmen
  surname: Mir
  fullname: Mir, Maria Carmen
  organization: Fundación Instituto Valenciano Oncología
– sequence: 22
  givenname: Francesco
  orcidid: 0000-0003-2812-5553
  surname: Claps
  fullname: Claps, Francesco
  organization: Fundación Instituto Valenciano Oncología
– sequence: 23
  givenname: Young Deuk
  surname: Choi
  fullname: Choi, Young Deuk
  organization: Yonsei University College of Medicine
– sequence: 24
  givenname: Won Sik
  surname: Ham
  fullname: Ham, Won Sik
  organization: Yonsei University College of Medicine
– sequence: 25
  givenname: Glen Denmer
  surname: Santok
  fullname: Santok, Glen Denmer
  organization: National Kidney and Transplant Institute
– sequence: 26
  givenname: John Paul
  surname: Tadifa
  fullname: Tadifa, John Paul
  organization: National Kidney and Transplant Institute
– sequence: 27
  givenname: Justin
  surname: Syling
  fullname: Syling, Justin
  organization: National Kidney and Transplant Institute
– sequence: 28
  givenname: Maria
  surname: Furlan
  fullname: Furlan, Maria
  organization: ASST‐Spedali Civili
– sequence: 29
  givenname: Claudio
  surname: Simeone
  fullname: Simeone, Claudio
  organization: ASST‐Spedali Civili
– sequence: 30
  givenname: Maida
  surname: Bada
  fullname: Bada, Maida
  organization: Hospital S. Bassiano, Bassano del Grappa (VI)
– sequence: 31
  givenname: Antonio
  surname: Celia
  fullname: Celia, Antonio
  organization: Hospital S. Bassiano, Bassano del Grappa (VI)
– sequence: 32
  givenname: Diego M.
  orcidid: 0000-0001-9685-8631
  surname: Carrión
  fullname: Carrión, Diego M.
  organization: Torrejon University Hospital
– sequence: 33
  givenname: Alfredo
  surname: Aguilera Bazan
  fullname: Aguilera Bazan, Alfredo
  organization: La Paz University Hospital
– sequence: 34
  givenname: Cristina Ballesteros
  surname: Ruiz
  fullname: Ruiz, Cristina Ballesteros
  organization: La Paz University Hospital
– sequence: 35
  givenname: Manar
  surname: Malki
  fullname: Malki, Manar
  organization: Centre Frimley Park Hospital, Surrey
– sequence: 36
  givenname: Neil
  surname: Barber
  fullname: Barber, Neil
  organization: Centre Frimley Park Hospital, Surrey
– sequence: 37
  givenname: Muddassar
  surname: Hussain
  fullname: Hussain, Muddassar
  organization: Centre Frimley Park Hospital, Surrey
– sequence: 38
  givenname: Salvatore
  surname: Micali
  fullname: Micali, Salvatore
  organization: University of Modena and Reggio Emilia
– sequence: 39
  givenname: Stefano
  surname: Puliatti
  fullname: Puliatti, Stefano
  organization: University of Modena and Reggio Emilia
– sequence: 40
  givenname: Ahmed
  surname: Ghaith
  fullname: Ghaith, Ahmed
  organization: Tanta University
– sequence: 41
  givenname: Ayman
  surname: Hagras
  fullname: Hagras, Ayman
  organization: Tanta University
– sequence: 42
  givenname: Ayman M.
  surname: Ghoneem
  fullname: Ghoneem, Ayman M.
  organization: Tanta University
– sequence: 43
  givenname: Ahmed
  orcidid: 0000-0001-6817-6887
  surname: Eissa
  fullname: Eissa, Ahmed
  organization: Tanta University
– sequence: 44
  givenname: Abdulrahman
  surname: Alqahtani
  fullname: Alqahtani, Abdulrahman
  organization: King Saud Medical City
– sequence: 45
  givenname: Abdullah
  surname: Rumaih
  fullname: Rumaih, Abdullah
  organization: King Saud Medical City
– sequence: 46
  givenname: Abdelaziz
  surname: Alwahabi
  fullname: Alwahabi, Abdelaziz
  organization: King Saud Medical City
– sequence: 47
  givenname: Mohammed Jayed
  surname: Alenzi
  fullname: Alenzi, Mohammed Jayed
  organization: Al‐Jouf University
– sequence: 48
  givenname: Nicola
  orcidid: 0000-0001-7355-7625
  surname: Pavan
  fullname: Pavan, Nicola
  organization: Cattinara Hospital, University of Trieste
– sequence: 49
  givenname: Fabio
  orcidid: 0000-0002-3272-528X
  surname: Traunero
  fullname: Traunero, Fabio
  organization: Cattinara Hospital, University of Trieste
– sequence: 50
  givenname: Alessandro
  surname: Antonelli
  fullname: Antonelli, Alessandro
  organization: University of Verona
– sequence: 51
  givenname: Antonio Benito
  orcidid: 0000-0002-7890-040X
  surname: Porcaro
  fullname: Porcaro, Antonio Benito
  organization: University of Verona
– sequence: 52
  givenname: Ester
  surname: Illiano
  fullname: Illiano, Ester
  organization: University of Perugia
– sequence: 53
  givenname: Elisabetta
  surname: Costantini
  fullname: Costantini, Elisabetta
  organization: University of Perugia
– sequence: 54
  givenname: Koon Ho
  orcidid: 0000-0001-8588-7584
  surname: Rha
  fullname: Rha, Koon Ho
  organization: Yonsei University College of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36478459$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1u1TAQRi1URG8LC14AWWIDEmn9F8dmV1UtFFViQ9eRrz1pfUnsYCeFPAcvXKe3sEBiNiONjs6M5jtCByEGQOg1JSe01KnfzSe0pkQ9QxsqBKsYEewAbYimulK0YYfoKOcdIZQzql6gQy5Fo0StN-j3xa8JUjA9vje9d2byMeDY4SWGDB6HOMTbZAY8JnDeTj7cYnuXYvAWf_cuwIKdz2AyYAf30MdxgDBh0xUpHk2afDEHGO8S2CkOy0d8FrAPjyvXVab_gIe5n7yFdYjzNLvlJXremT7Dq6d-jG4uL76df66uv366Oj-7rixvGlVZw6mAmoKgesuBSrflUgnmOt11kgkhnQVZKyGENVJLviXSMFleQ0jTiJofo3d775jijxny1A4-W-h7EyDOuWVNzTnRutEFffsPuovz-raVUkypcgor1Ps9ZVPMOUHXjskPJi0tJe2aVFuSah-TKuybJ-O8HcD9Jf9EU4DTPfDT97D839RefbnZKx8A-uahSQ
CitedBy_id crossref_primary_10_1111_iju_15125
crossref_primary_10_1016_j_urolonc_2023_09_015
crossref_primary_10_1111_iju_15145
Cites_doi 10.1016/j.eururo.2018.08.037
10.1016/j.eururo.2016.08.060
10.1016/j.juro.2009.01.112
10.1016/j.juro.2017.04.100
10.1053/j.ackd.2010.05.002
10.1016/j.urolonc.2014.03.012
10.1111/bju.14839
10.1016/j.eururo.2016.11.038
10.1016/j.euo.2018.06.015
10.1056/NEJMoa041031
10.1016/j.juro.2010.09.131
10.2215/CJN.11491116
10.1016/j.eururo.2010.12.013
10.1111/bju.13994
10.1016/j.urology.2013.03.068
10.1016/j.eururo.2018.11.021
10.7326/0003-4819-139-2-200307150-00013
10.1016/S1470-2045(06)70803-8
10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
10.1016/j.juro.2008.08.036
10.1097/JU.0000000000001549
10.1186/1471-2105-12-77
10.7326/0003-4819-130-6-199903160-00002
10.1016/j.eururo.2016.03.023
10.1016/j.juro.2006.03.090
10.1097/EDE.0b013e3181c30fb2
10.1159/000343526
10.1016/j.juro.2011.03.154
10.1111/iju.13705
10.1111/bju.14250
ContentType Journal Article
Copyright 2022 The Japanese Urological Association.
2023 The Japanese Urological Association
Copyright_xml – notice: 2022 The Japanese Urological Association.
– notice: 2023 The Japanese Urological Association
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7X8
DOI 10.1111/iju.15108
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

MEDLINE
Calcium & Calcified Tissue Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1442-2042
EndPage 317
ExternalDocumentID 10_1111_iju_15108
36478459
IJU15108
Genre researchArticle
Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
29J
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YUY
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7X8
ID FETCH-LOGICAL-c3778-ca314e51e419b3e16db36842df9ff62446dce658444ca6963b06a260420077453
IEDL.DBID DR2
ISSN 0919-8172
1442-2042
IngestDate Thu Oct 17 16:35:50 EDT 2024
Thu Oct 10 16:58:20 EDT 2024
Fri Aug 23 03:04:44 EDT 2024
Sat Nov 02 12:27:01 EDT 2024
Sat Aug 24 00:50:17 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords external validation
chronic kidney disease
functional outcomes
Yonsei nomogram
partial nephrectomy
Language English
License 2022 The Japanese Urological Association.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3778-ca314e51e419b3e16db36842df9ff62446dce658444ca6963b06a260420077453
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7355-7625
0000-0002-9294-2665
0000-0001-9685-8631
0000-0003-2812-5553
0000-0001-5237-0888
0000-0002-7890-040X
0000-0001-8588-7584
0000-0001-7045-7725
0000-0002-1994-1324
0000-0001-6817-6887
0000-0002-3272-528X
0000-0001-5947-3206
PMID 36478459
PQID 2782883142
PQPubID 2045142
PageCount 318
ParticipantIDs proquest_miscellaneous_2753309979
proquest_journals_2782883142
crossref_primary_10_1111_iju_15108
pubmed_primary_36478459
wiley_primary_10_1111_iju_15108_IJU15108
PublicationCentury 2000
PublicationDate March 2023
2023-03-00
20230301
PublicationDateYYYYMMDD 2023-03-01
PublicationDate_xml – month: 03
  year: 2023
  text: March 2023
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Hoboken
PublicationTitle International journal of urology
PublicationTitleAlternate Int J Urol
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2018; 122
2018; 121
2003; 139
2019; 75
2009; 181
2019; 2
2010; 17
2021; 205
2006; 7
2006; 176
2019; 124
2016; 72
2011; 12
2016; 70
2011; 59
2017; 198
1996; 15
2018; 25
2008; 180
2010; 21
2004; 351
2017; 71
2018; 118
2017; 12
2018
2013; 82
1999; 130
2018; 74
2012; 6
2011; 185
2014; 32
2011; 186
36541076 - Int J Urol. 2023 Mar;30(3):317. doi: 10.1111/iju.15125
36653123 - Int J Urol. 2023 Mar;30(3):318. doi: 10.1111/iju.15145
e_1_2_12_4_1
e_1_2_12_3_1
e_1_2_12_6_1
e_1_2_12_5_1
e_1_2_12_19_1
e_1_2_12_18_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_16_1
e_1_2_12_20_1
e_1_2_12_21_1
e_1_2_12_22_1
e_1_2_12_23_1
e_1_2_12_24_1
e_1_2_12_25_1
e_1_2_12_26_1
e_1_2_12_27_1
e_1_2_12_28_1
e_1_2_12_29_1
Dawidek MT (e_1_2_12_33_1) 2018; 118
e_1_2_12_30_1
e_1_2_12_31_1
e_1_2_12_32_1
e_1_2_12_34_1
e_1_2_12_15_1
e_1_2_12_14_1
e_1_2_12_13_1
e_1_2_12_12_1
e_1_2_12_8_1
e_1_2_12_11_1
e_1_2_12_7_1
e_1_2_12_10_1
e_1_2_12_9_1
References_xml – volume: 351
  start-page: 1296
  year: 2004
  end-page: 305
  article-title: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
  publication-title: N Engl J Med
– volume: 72
  start-page: 64
  year: 2016
  end-page: 75
  article-title: Collaborative review of risk benefit trade‐offs between partial and radical nephrectomy in the Management of Anatomically Complex Renal Masses
  publication-title: Eur Urol
– volume: 121
  start-page: 93
  issue: 1
  year: 2018
  end-page: 100
  article-title: Analysis of survival for patients with chronic kidney disease primarily related to renal cancer surgery
  publication-title: BJU Int
– volume: 32
  start-page: 1024
  year: 2014
  end-page: 30
  article-title: Nephron‐sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4‐cm cutoff
  publication-title: Urol Oncol
– volume: 21
  start-page: 128
  year: 2010
  end-page: 38
  article-title: Assessing the performance of prediction models: a framework for traditional and novel measures
  publication-title: Epidemiology
– volume: 74
  start-page: 833
  issue: 6
  year: 2018
  end-page: 9
  article-title: A nomogram to predict significant estimated glomerular filtration rate reduction after robotic partial nephrectomy
  publication-title: Eur Urol
– volume: 139
  start-page: 137
  issue: 2
  year: 2003
  end-page: 47
  article-title: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification
  publication-title: Ann Intern Med
– volume: 15
  start-page: 361
  year: 1996
  end-page: 87
  article-title: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
  publication-title: Stat Med
– volume: 75
  start-page: 766
  issue: 5
  year: 2019
  end-page: 72
  article-title: Predicting renal function outcomes after partial and radical nephrectomy
  publication-title: Eur Urol
– year: 2018
– volume: 186
  start-page: 405
  year: 2011
  end-page: 10
  article-title: Effect of parenchymal volume preservation on kidney function after partial nephrectomy
  publication-title: J Urol
– volume: 122
  start-page: 618
  issue: 4
  year: 2018
  end-page: 26
  article-title: Functional and oncological outcomes of open, laparoscopic and robot‐assisted partial nephrectomy: a multicentre comparative matched‐pair analyses with a median of 5 years' follow‐up
  publication-title: BJU Int
– volume: 205
  start-page: 1310
  issue: 5
  year: 2021
  end-page: 20
  article-title: New baseline renal function after radical or partial nephrectomy: a simple and accurate predictive model
  publication-title: J Urol
– volume: 118
  start-page: 246
  year: 2018
  end-page: 7
  article-title: Assessing time of full renal recovery following minimally invasive partial nephrectomy
  publication-title: Urology
– volume: 59
  start-page: 543
  issue: 4
  year: 2011
  end-page: 52
  article-title: A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron‐sparing surgery and radical nephrectomy for low‐stage renal cell carcinoma
  publication-title: Eur Urol
– volume: 2
  start-page: 106
  issue: 1
  year: 2019
  end-page: 9
  article-title: Development and internal validation of a nomogram for predicting renal function after partial nephrectomy
  publication-title: Eur Urol Oncol
– volume: 82
  start-page: 263
  year: 2013
  end-page: 8
  article-title: Parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis
  publication-title: Urology
– volume: 70
  start-page: 558
  year: 2016
  end-page: 61
  article-title: End‐stage renal disease after renal surgery in patients with normal preoperative kidney function: balancing surgical strategy and individual disorders at baseline
  publication-title: Eur Urol
– volume: 6
  start-page: 129
  year: 2012
  end-page: 35
  article-title: Prognostic factors influencing postoperative development of chronic kidney disease in patients with small renal tumors who underwent partial nephrectomy
  publication-title: Curr Urol
– volume: 12
  start-page: 77
  year: 2011
  article-title: pROC: an open‐source package for R and S+ to analyze and compare ROC curves
  publication-title: BMC Bioinformatics
– volume: 180
  start-page: 2363
  year: 2008
  article-title: Factors predicting renal functional outcome after partial nephrectomy
  publication-title: J Urol
– volume: 124
  start-page: 999
  issue: 6
  year: 2019
  end-page: 1005
  article-title: Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function
  publication-title: BJU Int
– volume: 25
  start-page: 690
  issue: 7
  year: 2018
  end-page: 7
  article-title: Yonsei nomogram: a predictive model of new‐onset chronic kidney disease after on‐clamp partial nephrectomy in patients with T1 renal tumors
  publication-title: Int J Urol
– volume: 176
  start-page: 472
  year: 2006
  end-page: 6
  article-title: Prognostic nomogram for renal insufficiency after radical or partial nephrectomy
  publication-title: J Urol
– volume: 198
  start-page: 520
  year: 2017
  end-page: 9
  article-title: Renal mass and localized renal cancer: AUA guideline
  publication-title: J Urol
– volume: 130
  start-page: 461
  year: 1999
  end-page: 70
  article-title: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group
  publication-title: Ann Int Med
– volume: 17
  start-page: 302
  year: 2010
  end-page: 7
  article-title: The aging kidney: physiological changes
  publication-title: Adv Chronic Kidney Dis
– volume: 71
  start-page: 606
  year: 2017
  end-page: 17
  article-title: Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta‐analysis of comparative studies
  publication-title: Eur Urol
– volume: 7
  start-page: 735
  year: 2006
  end-page: 40
  article-title: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study
  publication-title: Lancet Oncol
– volume: 181
  start-page: 2451
  issue: 6
  year: 2009
  end-page: 60
  article-title: Estimation and prediction of renal function in patients with renal tumor
  publication-title: J Urol
– volume: 185
  start-page: 421
  year: 2011
  end-page: 7
  article-title: Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function
  publication-title: J Urol
– volume: 12
  start-page: 2032
  issue: 12
  year: 2017
  end-page: 45
  article-title: Diabetic kidney disease challenges, progress, and possibilities
  publication-title: Clin J Am Soc Nephrol
– ident: e_1_2_12_12_1
  doi: 10.1016/j.eururo.2018.08.037
– ident: e_1_2_12_34_1
  doi: 10.1016/j.eururo.2016.08.060
– ident: e_1_2_12_9_1
  doi: 10.1016/j.juro.2009.01.112
– ident: e_1_2_12_2_1
  doi: 10.1016/j.juro.2017.04.100
– ident: e_1_2_12_26_1
  doi: 10.1053/j.ackd.2010.05.002
– ident: e_1_2_12_5_1
  doi: 10.1016/j.urolonc.2014.03.012
– ident: e_1_2_12_27_1
  doi: 10.1111/bju.14839
– ident: e_1_2_12_31_1
  doi: 10.1016/j.eururo.2016.11.038
– ident: e_1_2_12_11_1
  doi: 10.1016/j.euo.2018.06.015
– ident: e_1_2_12_18_1
– ident: e_1_2_12_7_1
  doi: 10.1056/NEJMoa041031
– ident: e_1_2_12_23_1
  doi: 10.1016/j.juro.2010.09.131
– ident: e_1_2_12_29_1
  doi: 10.2215/CJN.11491116
– ident: e_1_2_12_6_1
  doi: 10.1016/j.eururo.2010.12.013
– ident: e_1_2_12_32_1
  doi: 10.1111/bju.13994
– ident: e_1_2_12_20_1
– ident: e_1_2_12_24_1
  doi: 10.1016/j.urology.2013.03.068
– ident: e_1_2_12_10_1
  doi: 10.1016/j.eururo.2018.11.021
– ident: e_1_2_12_15_1
  doi: 10.7326/0003-4819-139-2-200307150-00013
– ident: e_1_2_12_3_1
  doi: 10.1016/S1470-2045(06)70803-8
– ident: e_1_2_12_16_1
  doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
– ident: e_1_2_12_21_1
  doi: 10.1016/j.juro.2008.08.036
– ident: e_1_2_12_28_1
  doi: 10.1097/JU.0000000000001549
– ident: e_1_2_12_19_1
  doi: 10.1186/1471-2105-12-77
– ident: e_1_2_12_14_1
  doi: 10.7326/0003-4819-130-6-199903160-00002
– ident: e_1_2_12_4_1
  doi: 10.1016/j.eururo.2016.03.023
– ident: e_1_2_12_8_1
  doi: 10.1016/j.juro.2006.03.090
– volume: 118
  start-page: 246
  year: 2018
  ident: e_1_2_12_33_1
  article-title: Assessing time of full renal recovery following minimally invasive partial nephrectomy
  publication-title: Urology
  contributor:
    fullname: Dawidek MT
– ident: e_1_2_12_17_1
  doi: 10.1097/EDE.0b013e3181c30fb2
– ident: e_1_2_12_22_1
  doi: 10.1159/000343526
– ident: e_1_2_12_30_1
  doi: 10.1016/j.juro.2011.03.154
– ident: e_1_2_12_13_1
  doi: 10.1111/iju.13705
– ident: e_1_2_12_25_1
  doi: 10.1111/bju.14250
SSID ssj0013218
Score 2.389881
Snippet Objective To externally validate Yonsei nomogram. Methods From 2000 through 2018, 3526 consecutive patients underwent on‐clamp PN for cT1 renal masses at 23...
To externally validate Yonsei nomogram. From 2000 through 2018, 3526 consecutive patients underwent on-clamp PN for cT1 renal masses at 23 centers were...
Abstract Objective To externally validate Yonsei nomogram. Methods From 2000 through 2018, 3526 consecutive patients underwent on‐clamp PN for cT1 renal masses...
ObjectiveTo externally validate Yonsei nomogram.MethodsFrom 2000 through 2018, 3526 consecutive patients underwent on‐clamp PN for cT1 renal masses at 23...
To externally validate Yonsei nomogram.OBJECTIVETo externally validate Yonsei nomogram.From 2000 through 2018, 3526 consecutive patients underwent on-clamp PN...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 308
SubjectTerms Calibration
chronic kidney disease
Epidermal growth factor receptors
external validation
functional outcomes
Glomerular Filtration Rate
Humans
Kidney diseases
Kidney Neoplasms - pathology
Middle Aged
Nephrectomy
Nephrectomy - methods
Nomograms
partial nephrectomy
Renal Insufficiency, Chronic - surgery
Retrospective Studies
Yonsei nomogram
Title External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fiju.15108
https://www.ncbi.nlm.nih.gov/pubmed/36478459
https://www.proquest.com/docview/2782883142
https://www.proquest.com/docview/2753309979
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS-RAEC5EQby4vnfUlVY8eHAGk3Re7mlcHVTQgzjgQQj9hCgmg84cxr_hH7aqk4zjysLiLdDpdKe7qrseX38NsJ8oaYVFTROC0owylG1ppd-WKU91osWRjug08tV1dN7nl3fh3Qz8bs7CVPwQk4AbaYZbr0nBhXyZUvL8YdTB7cod9PWCmOBcpzf-VAbBxfZwO6QwV-zXrEKE4pnU_LwXfTEwP9urbsPp_YD7pqsVzuSxMxrKjnr9i8Xxm_-yBIu1Icq6leQsw4wpVmD-qk61r8LbWc0PzVAW8-rmJVZaNib4dc6K8skBu9jgmaoQeJqpimiXPea6MGNW536Y_sAlMXclORuQvOKXC0OipIbl0_iYdQuWT4cnD5kDOxJ6FKs4Gtw16PfObv-ct-sbHNoqiNE9VSLwuAk9w71UBsaLtAwo8adtam2ElkWklSEbiHMlIlwL5FEk0MPiFEGNeRisw2xRFuYnsFgoFCnfakEE-r4WOkyML2NlrVXo5bZgr5nLbFARdWSNg4PDm7nhbcF2M8tZrasvmY9GUpJgR_0W7E6KUcsodSIKU47oHULhpmmctmCjko5JK8TAn_AQSw7cHP-7-ezisu8eNv__1S1YoBvuK9jbNswOn0fmF9pBQ7kDc92T05PejhP8d0yjCPA
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB4hkAqX0vJqIJRtxYEDiRJ7_ap6QRQUHuGAiMQFWfuUDMKOQnJI_0b_MDNrOw1USBU3S-v1rndndmdnvv0GYD9W0gqLmiYEhRllIFvSSq8lE57oWIuODuk2cv8q7A34-W1wuwA_67swJT_EzOFGmuHWa1JwckjPaXl2P2njfkU3fZdQ3X1K3PDr2puLITjvHm6I5OiKvIpXiHA8s6ovd6N_TMyXFqvbck5X4a7ubIk0eWhPxrKtfr_icXzv33yCj5Utyo5K4fkMCyZfgw_9Ktq-Dn9OKopohuKYlcmXWGHZlBDYGcuLR4ftYsMRVSH8NFMl1y57yHRupqwK_zD9F5rEXFZyNiSRxS_nhqRJjYvH6Q92lLNs3kN5yBzekQCkWMUx4W7A4PTk5rjXqpI4tJQf4QlVCb_LTdA1vJtI33RDLX2K_WmbWBuicRFqZcgM4lyJEJcD2QkFHrI4OVEjHvibsJgXufkCLBIKpcqzWhCHvqeFDmLjyUhZaxUedBvwvZ7MdFhydaT1GQeHN3XD24BmPc1ppa5PqYd2UhxjR70GfJsVo6JR9ETkppjQOwTETZIoacBWKR6zVoiEP-YBlhy4SX67-fTsfOAetv__1T1Y7t30L9PLs6uLHVihhPclCq4Ji-PRxOyiWTSWX530PwNf7AuW
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB4hkBCXQimUQNpuEYcemiix16_2FLVEJC0IoUbigGTtUzJR7Cgkh_A3-oc7s7bT0KoS6s3Sev3Yndn9dubbbwHOYiWtsOhpQlCaUQayJa30WjLhiY616OiQdiNfXoUXIz68DW434HO9F6bUh1gF3Mgz3HhNDj7Vds3Js_tFG6cr2ui7xUNEvoSIbry1FIIL7uF8SHGuyKtkhYjGs6r6dDL6C2E-Baxuxunvwl39rSXRZNxezGVbPf4h4_ifP7MHLyokynql6byEDZPvw_ZllWt_BT_PK4FohsaYlUcvscKyJfGvM5YXE8fsYtMZVSH2NFOl0i4bZzo3S1Ylf5j-TUxi7kxyNiWDxSfnhmxJzYvJ8hPr5Sxbj09-ZI7tSPRRrOJ0cA9g1D__8eWiVR3h0FJ-hOtTJfwuN0HX8G4ifdMNtfQp86dtYm2I0CLUyhAI4lyJEAcD2QkFLrE4hVAjHviHsJkXuTkCFgmFNuVZLUhB39NCB7HxZKSstQqXuQ04rfsynZZKHWm9wsHmTV3zNqBZ93JaOetD6iFKimP8UK8B71fF6GaUOxG5KRZ0D9FwkyRKGvC6tI7VW0iCP-YBlnxwffzv16eD4chdHD__1newff21n34fXH07gR067b6kwDVhcz5bmDeIiebyrbP9X0IKCkU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=External+validation+of+yonsei+nomogram+predicting+chronic+kidney+disease+development+after+partial+nephrectomy%3A+An+international%2C+multicenter+study&rft.jtitle=International+journal+of+urology&rft.au=Abdel+Raheem%2C+Ali&rft.au=Landi%2C+Isotta&rft.au=Alowidah%2C+Ibrahim&rft.au=Capitanio%2C+Umberto&rft.date=2023-03-01&rft.issn=1442-2042&rft.eissn=1442-2042&rft.volume=30&rft.issue=3&rft.spage=308&rft_id=info:doi/10.1111%2Fiju.15108&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0919-8172&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0919-8172&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0919-8172&client=summon